Endocrinology/Metabolics Market Research Reports & Industry Analysis
Endocrinologists are specially trained doctors in treating hormone imbalances and problems. Most endocrine disorders are chronic and need continuous treatment. Some commonly treated endocrine disorders include diabetes mellitus, thyroid and hyperparathyroid disorders, and osteoporosis. Some less common but serious endocrine disorders include, but are not limited to: Addison’s disease, Cushing’s syndrome, pheochromocytoma, and disorders of sexual development.
In the United States, the most common endocrine disease is diabetes mellitus. Diabetes mellitus is a group of diseases categorized by a deficiency in insulin production or the ability of the body to use it. According to the American Diabetes Association, in 2010, 25.8 million children and adults in the United States (8.3% of the population) have diabetes. The study and treatment of diabetes has made endocrinology/metabolics one of the most in-demand and important medical sects.
Endocrinology/Metabolics Industry Research & Market Reports
-
Metabolic Disorder Therapeutics
... by 2030, growing at a CAGR of 6.8% over the analysis period 2023-2030. Diabetes Therapeutics, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$91.9 Billion by ... Read More
-
Global Addisons Disease Therapeutics Market 2024-2028
... disease therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
Global Human Growth Hormone Market 2024-2028
... period. The report on the human growth hormone market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an ... Read More
-
Rare Endocrine Disease Treatment
... reach US$14.4 Billion by 2030, growing at a CAGR of 3.5% over the analysis period 2023-2030. Acromegaly Treatment, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach ... Read More
-
Hormone Replacement Therapy (HRT)
... reach US$44.6 Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2023-2030. Estrogen Hormone Replacement Therapy, one of the segments analyzed in the report, is expected to record a 6.3% CAGR ... Read More
-
Metabolic Testing Solutions
... by 2030, growing at a CAGR of 6.6% over the analysis period 2023-2030. CPET Systems, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$324.1 Million by ... Read More
-
Testosterone Replacement Therapy (TRT)
... reach US$2.5 Billion by 2030, growing at a CAGR of 4.1% over the analysis period 2023-2030. TRT Topicals, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach ... Read More
-
Human Growth Hormone Drugs
... reach US$5.2 Billion by 2030, growing at a CAGR of 4.2% over the analysis period 2023-2030. Subcutaneous Administration, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach ... Read More
-
Endocrinology Drugs Market by Therapy Area (Diabetes Drugs, Human Growth Hormone, Thyroid Hormone Disorders), Distribution Channel (Hospital pharmacies, Online pharmacies, Retail pharmacies) - Global Forecast 2024-2030
... 32.78 billion in 2023 and expected to reach USD 35.05 billion in 2024, at a CAGR 7.34% to reach USD 53.85 billion by 2030. Endocrinology drugs are medications that are used to treat disorders of ... Read More
-
Somatotropin Deficiency – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Somatotropin Deficiency market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Somatotropin Deficiency market report provides current treatment practices, emerging drugs, Somatotropin ... Read More
-
Metabolic Acidosis – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Metabolic Acidosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Metabolic Acidosis market report provides current treatment practices, emerging drugs, Metabolic ... Read More
-
Pediatric Growth Hormone Deficiency (PGHD) – Market Insight, Epidemiology, and Market Forecast – 2034
... the Pediatric Growth Hormone Deficiency (PGHD), historical and forecasted epidemiology as well as the Pediatric Growth Hormone Deficiency (PGHD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. ... Read More
-
Global Endocrinology Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... 2023 and is forecast to a readjusted size of USD 140400 million by 2030 with a CAGR of 5.0% during review period. Endocrinology drugs are used to treat hormonal problems such as hypothyroidism, diabetes and ... Read More
-
Global Endocrinology Drugs Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
2024 Endocrine, Nutritional and Metabolic Diseases, and Immunity Disorders Global Market Size & Growth Report with Updated Recession Risk Impact
... Growth Report covers market size, revenue, growth, and share across 4 global regions (The Americas, Europe, Asia & Oceania, Africa & Middle East), 22 subregions, and 195 countries. Figures are from 2012 through 2023, with ... Read More
-
Global Metabolic Testing Databank Market Report
... 2029. Body Composition Analyzers segment is expected to be the highest contributor to this market, with $256.7 Million in 2020, and is anticipated to reach $394.6 Million by 2029, registering a CAGR of 4.94%. Body ... Read More
-
Laboratory Developed Tests Market Size, Share & Trends Analysis Report By Technology (Immunoassay, Molecular Diagnostics), By Application (Oncology, Nutritional & Metabolic Disease), By Region, And Segment Forecasts, 2024 - 2030
... & Trends The global laboratory developed tests market size is expected to reach USD 19.85 billion by 2030, expanding at a CAGR of 7.05% from 2024 to 2030, according to a new report by Grand ... Read More
-
Blood Testing Market by Type (Basic Metabolic Panels, Complete Blood Count Tests, Complete Metabolic Panels), Application (Allergies, Autoimmune Diseases, Cancer/Noncancerous Blood Disorders), End-User - Global Forecast 2024-2030
... USD 94.49 billion in 2023 and expected to reach USD 100.02 billion in 2024, at a CAGR 6.34% to reach USD 145.37 billion by 2030. Blood testing is a clinical procedure that involves analyzing a ... Read More
-
Endocrinology Drugs Market Size, Trends, Analysis, and Outlook By Therapy Area (Adrenal Insufficiency, Diabetes, Thyroid Hormone Disorder, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region, Country, Segment, and Companies, 2024-2030
... global Endocrinology Drugs market size is poised to register 7.64% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Endocrinology Drugs market across ... Read More
-
The 2025-2030 World Outlook for Metabolic Testing
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Metabolic Testing Solutions
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Hormone Replacement Therapies
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
Endocrinology Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... impacted the endocrinology drugs market since many research studies demonstrated that people with thyroid disorders and diabetes are more prone to COVID-19 infection, creating a significant demand for the appropriate use of various endocrine drugs. ... Read More
-
2023 Endocrine, Nutritional and Metabolic Diseases, and Immunity Disorders Global Market Size & Growth Report with COVID-19 & Recession Risk Impact
... & Growth Report covers market size, revenue, growth, and share across 4 global regions (The Americas, Europe, Asia & Oceania, Africa & Middle East), 22 subregions, and 216 countries. Figures are from 2014 through 2022, ... Read More
-
Endocrinology Tests Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
... Key Companies, 2023 Update provides comprehensive information about the Endocrinology Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Endocrinology ... Read More
Research Assistance
